Y O Aksenova, A A Petrukhina, Y F Osmolovskaya, I V Zhirov, A G Beniashvili, M A Morozova, G E Rupchev, A A Galich, O N Tolstukhina, S N Tereshchenko
{"title":"[慢性心力衰竭患者的认知障碍及其对治疗依从性的影响]。","authors":"Y O Aksenova, A A Petrukhina, Y F Osmolovskaya, I V Zhirov, A G Beniashvili, M A Morozova, G E Rupchev, A A Galich, O N Tolstukhina, S N Tereshchenko","doi":"10.26442/00403660.2025.07.203351","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To evaluate cognitive impairment in patients with chronic heart failure (CHF) and its impact on treatment adherence.</p><p><strong>Materials and methods: </strong>The study included 120 hospitalized patients with CHF regardless of left ventricular ejection fraction aged from 20 to 79 years with different etiology of CHF. All patients underwent complex neuropsychological testing to determine the presence and severity of CH, psychoemotional status, as well as adherence to treatment and quality of life. After 6 months, the group of patients who came for a follow-up visit was re-evaluated for these indicators. The first group of patients was compared with the second group of patients who did not come for a follow-up visit after 6 months, although the conditions of the study were explained to all single patients.</p><p><strong>Results: </strong>Out of 120 patients, 28 (23.3%) patients came for a follow-up visit, 3 (2.5%) patients died, the rest of the study participants [89 (74.2%) patients] - refused a face-to-face visit to the physician. On MoCA after 6 months, patients showed a higher mean score of 23.89±2.67 (<i>p</i>=0.003). Percentage-wise, 53.6% of patients showed improvement in cognitive functioning scores. Group 1 patients (<i>n</i>=28) demonstrated a medium relationship between treatment adherence on the Morisky-Green questionnaire and RBM-7 (<i>r</i>=-0.532) in contrast to group 2 patients (<i>n</i>=89) who demonstrated a weak relationship (<i>r</i>=-0.283).</p><p><strong>Conclusion: </strong>The complex relationship between CHF and cognitive impairment emphasizes the need for a comprehensive approach to patient care. Patients who demonstrate high compliance and good subjective assessment of their cognitive functioning, although some cognitive functions are reduced, are the most motivated to comply with the doctor's recommendations and follow-up.</p>","PeriodicalId":22209,"journal":{"name":"Terapevticheskii Arkhiv","volume":"97 7","pages":"562-570"},"PeriodicalIF":0.3000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Cognitive impairment in patients with chronic heart failure and its impact on adherence to treatment].\",\"authors\":\"Y O Aksenova, A A Petrukhina, Y F Osmolovskaya, I V Zhirov, A G Beniashvili, M A Morozova, G E Rupchev, A A Galich, O N Tolstukhina, S N Tereshchenko\",\"doi\":\"10.26442/00403660.2025.07.203351\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>To evaluate cognitive impairment in patients with chronic heart failure (CHF) and its impact on treatment adherence.</p><p><strong>Materials and methods: </strong>The study included 120 hospitalized patients with CHF regardless of left ventricular ejection fraction aged from 20 to 79 years with different etiology of CHF. All patients underwent complex neuropsychological testing to determine the presence and severity of CH, psychoemotional status, as well as adherence to treatment and quality of life. After 6 months, the group of patients who came for a follow-up visit was re-evaluated for these indicators. The first group of patients was compared with the second group of patients who did not come for a follow-up visit after 6 months, although the conditions of the study were explained to all single patients.</p><p><strong>Results: </strong>Out of 120 patients, 28 (23.3%) patients came for a follow-up visit, 3 (2.5%) patients died, the rest of the study participants [89 (74.2%) patients] - refused a face-to-face visit to the physician. On MoCA after 6 months, patients showed a higher mean score of 23.89±2.67 (<i>p</i>=0.003). Percentage-wise, 53.6% of patients showed improvement in cognitive functioning scores. Group 1 patients (<i>n</i>=28) demonstrated a medium relationship between treatment adherence on the Morisky-Green questionnaire and RBM-7 (<i>r</i>=-0.532) in contrast to group 2 patients (<i>n</i>=89) who demonstrated a weak relationship (<i>r</i>=-0.283).</p><p><strong>Conclusion: </strong>The complex relationship between CHF and cognitive impairment emphasizes the need for a comprehensive approach to patient care. Patients who demonstrate high compliance and good subjective assessment of their cognitive functioning, although some cognitive functions are reduced, are the most motivated to comply with the doctor's recommendations and follow-up.</p>\",\"PeriodicalId\":22209,\"journal\":{\"name\":\"Terapevticheskii Arkhiv\",\"volume\":\"97 7\",\"pages\":\"562-570\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2025-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Terapevticheskii Arkhiv\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26442/00403660.2025.07.203351\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Terapevticheskii Arkhiv","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26442/00403660.2025.07.203351","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
[Cognitive impairment in patients with chronic heart failure and its impact on adherence to treatment].
Aim: To evaluate cognitive impairment in patients with chronic heart failure (CHF) and its impact on treatment adherence.
Materials and methods: The study included 120 hospitalized patients with CHF regardless of left ventricular ejection fraction aged from 20 to 79 years with different etiology of CHF. All patients underwent complex neuropsychological testing to determine the presence and severity of CH, psychoemotional status, as well as adherence to treatment and quality of life. After 6 months, the group of patients who came for a follow-up visit was re-evaluated for these indicators. The first group of patients was compared with the second group of patients who did not come for a follow-up visit after 6 months, although the conditions of the study were explained to all single patients.
Results: Out of 120 patients, 28 (23.3%) patients came for a follow-up visit, 3 (2.5%) patients died, the rest of the study participants [89 (74.2%) patients] - refused a face-to-face visit to the physician. On MoCA after 6 months, patients showed a higher mean score of 23.89±2.67 (p=0.003). Percentage-wise, 53.6% of patients showed improvement in cognitive functioning scores. Group 1 patients (n=28) demonstrated a medium relationship between treatment adherence on the Morisky-Green questionnaire and RBM-7 (r=-0.532) in contrast to group 2 patients (n=89) who demonstrated a weak relationship (r=-0.283).
Conclusion: The complex relationship between CHF and cognitive impairment emphasizes the need for a comprehensive approach to patient care. Patients who demonstrate high compliance and good subjective assessment of their cognitive functioning, although some cognitive functions are reduced, are the most motivated to comply with the doctor's recommendations and follow-up.
期刊介绍:
Терапевтический архив
The journal was founded by the prominent Russian therapists M.P. Konchalovsky and G.F. Lang in 1923. Then its editors-in-chief were Professors V.N. Vinogradov and A.G. Gukasyan. Since 1972, E.I. Chazov, Academician of the Russian Academy of Sciences, has been heading the editorial board of the journal.
Over 90 years, there have been more than 1000 issues where the authors and editorial staff have done their best for readers to keep abreast of current advances in medical science and practice and for physicians to master the advanced principles of recognition and treatment of a wide spectrum of visceral diseases.
The papers published in the journal (editorials, original articles, lectures, reviews, etc.) cover both current scientific achievements and practical experience in diagnosing, treating, and preventing visceral diseases. The authors of publications are not only Russian, but also foreign scientists and physicians. All papers are peer-reviewed by highly qualified Russian specialists.
The journal is published monthly. Traditionally, each issue has predominantly certain thematic areas covering individual therapy specializations. Every year, one of the issues is devoted to related problems in practical medicine (allergology and immunology, neurology and psychiatry, obstetrics, oncology, etc.). This all draws the attention of the reading public to the journal.
The journal is indexed in RSCI (Russian Science Citation Index), PubMed/Medline, Index Medicus, Scopus/EMBASE, Web of Science Core Collection (Science Citation Index Expanded), Web of Science (Russian Science Citation Index - RSCI, Current Contents Connect, BIOSIS Previews), Google Scholar, Ulrich''s Periodicals Directory.
The journal is included in the list of periodicals recommended by the Higher Attestation Committee for publishing the papers containing the basic materials of doctoral and candidate dissertations.
By the decision of the Presidium of the Russian Academy of Medical Sciences, the “Therapevticheskiy Arkhiv” was awarded the Botkin medal. It was admitted to the European Association of Sciences Editors (EASE).
The journal was honored with the Golden Press Fund decoration at the 13th International Press Professional Exhibition.